Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

LasX and Surnetics sign Memorandum of Understanding for Developing IVD and other Microfluidic Products

Published: Friday, September 06, 2013
Last Updated: Friday, September 06, 2013
Bookmark and Share
Companies are to partner on the development of precision-cut microfluidic products for use in the diagnostic, medical, and other life science markets.

LasX’s patented LaserSharp® laser digital converting technology is ideal for the high volume manufacturing of next-generation microfluidic platforms because of its unmatched precision. Laser converting technology delivers a more accurate, efficient, and flexible solution for processing today’s complex microfluidic products, from prototype to full-scale production.

Surnetics develops technology solutions for enabling and improving liquid flow within channels in microfluidic products. Surnetics has developed a patent portfolio for gradient coatings; for example, a coating that changes in hydrophilicity (or other properties) over the length of the channel. This technology allows for fluid to flow through a channel without the need for pumps, valves, wicking strips, or any other external force. The technology can be used to control flow features on a product while greatly reducing the cost and size of the product.

Tom Daul, Program Development Manager for LasX stated, “Together, these enabling technologies allow customers to achieve more accurate, cost-effective microfluidic platforms than ever before.” Brian Babcock, President and founder of Surnetics added, "We are very pleased to establish this relationship with LasX. They have been an industry leader in the manufacture of precision, high volume microfluidic products for life sciences and bring a great deal of product design and manufacturing expertise that can be combined with Surnetics’ expertise in coatings and fluid flow optimization. This agreement presents a tremendous opportunity for both companies to develop new product platforms using our combined capabilities.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!